T. Garriga-Baraut, “A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAPTM ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, Spain”, Allergol Immunopathol, vol. 52, no. 4, pp. 21–29, Jul. 2024, doi: 10.15586/aei.v52i4.1077.